Analyst firms · Guggenheim · NUVL
Guggenheim NUVL price target and rating history
Nuvalent Inc. (NUVL) · Health Care
Guggenheim rates Nuvalent Inc. (NUVL) Buy with a $122 price target, as of its latest action on Sep 4, 2025. It has published 3 rating actions on NUVL since July 2023, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $122
- Median target, all firms
- Too few
- Actions on NUVL
- 3
Guggenheim price target on NUVL
Every Guggenheim rating on NUVL
- Sep 4, 2025
- Feb 28, 2024
- Jul 24, 2023
How other firms rate NUVL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Mkt Perform | $124 | Jun 24, 2026 |
| Wells Fargo | Overweight | $116 | Mar 30, 2026 |
| Truist Securities | Buy | Nov 24, 2025 |
Questions about Guggenheim and NUVL
- What is Guggenheim's price target for NUVL?
- Guggenheim's latest stated price target for Nuvalent Inc. (NUVL) is $122, from its action on Sep 4, 2025.
- What is Guggenheim's rating on NUVL?
- Guggenheim rates NUVL Buy, a bullish rating, as of Sep 4, 2025.
- When did Guggenheim last change its view on NUVL?
- On Sep 4, 2025, Guggenheim resumes coverage at Buy, price target $122.
All Guggenheim ratingsNUVL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.